Identification of risk factors associated with loss of response to ustekinumab in Crohn's disease

Steve Hanauer  1     Bruce E. Sands  2     Brian G. Feagan  3     A Oortwijn  4     Roger van Kruchten  4     Victor Laliman  5     James Izanec  6     Joseph Adedokun     Long-Long Gao     Sheldon Sloan     Christopher Gasink     S Targan     Willem de Villiers     Paul Rutgeerts     Jean-Frédéric Colombel     Subrata Ghosh    
1 Feinberg School of Medicine, Northwestern University,Chicago,United States
2 Icahn School of Medicine at Mount Sinai,New York City,United States
3 Robarts Clinical Trials Inc.,London,Canada
4 Janssen Biologics BV,Leiden,Netherlands
5 AMARIS,Toronto,Canada
6 Janssen Scientific Affairs, LLC,Horsham,U

Session
Holistic management of IBD patients

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing